Literature DB >> 1691422

Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma.

M C Kew1, M Houghton, Q L Choo, G Kuo.   

Abstract

380 southern African blacks with hepatocellular carcinoma and 152 controls were studied. Antibodies to hepatitis C virus (HCV) were found in 110 patients and 1 control. 184 patients had evidence of current infection with hepatitis B virus (HBV) and 122 had had infection with this virus in the past. Only 47 patients had no markers of HCV or HBV infection. Among patients positive for HCV, there was a higher proportion of women and urban dwellers, and the average age was higher. In southern Africa, HCV is associated with hepatocellular carcinoma but HBV is present in a higher proportion of patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691422     DOI: 10.1016/0140-6736(90)90474-j

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 2.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

3.  Risk factors and prevention of hepatocellular carcinoma in HCV infection.

Authors:  L Benvegnù; A Alberti
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  Discrimination of hepatitis C virus in liver tissues from different patients with hepatocellular carcinomas by direct nucleotide sequencing of amplified cDNA of the viral genome.

Authors:  W H Chou; T Yoneyama; K Takeuchi; H Harada; I Saito; T Miyamura
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

Review 5.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

6.  Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor.

Authors:  C M Chen; L R You; L H Hwang; Y H Lee
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Hepatitis type C virus infection in patients with type B chronic liver disease.

Authors:  T Doi; G Yamada; H Endo; H Nishimoto; M Takahashi; R Miyamoto; S Fujiki; H Shimomura; M Mizuno; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1992-10

8.  Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells.

Authors:  C M Shih; S J Lo; T Miyamura; S Y Chen; Y H Lee
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Androgen associated hepatocellular carcinoma with an aggressive course.

Authors:  D Gleeson; M J Newbould; P Taylor; R F McMahon; B C Leahy; T W Warnes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

10.  Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis.

Authors:  Yasuji Arase; Fumitaka Suzuki; Yoshiyuki Suzuki; Norio Akuta; Masahiro Kobayashi; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Tetsuya Hosaka; Miharu Hirakawa; Satoshi Saito; Kenji Ikeda; Hiromitsu Kumada
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.